Philips third-quarter earnings drop

Article

Dutch conglomerate Philips Electronics reported disappointingsales and earnings last month, prompting renewed talk that a restructuringcould be in the cards for the Eindhoven company. The company'snew president, Cor Boonstra, has told analysts that he

Dutch conglomerate Philips Electronics reported disappointingsales and earnings last month, prompting renewed talk that a restructuringcould be in the cards for the Eindhoven company. The company'snew president, Cor Boonstra, has told analysts that he will eitherturn around or divest units that aren't performing to expectations.

For the third quarter (end-September), Philips reported earningsof 123 million Dutch guilders ($72.2 million), far below net incomeof 539 million guilders reported in the same period a year agoand below analysts' expectations. For the nine months to date,Philips has reported net income of 359 million guilders ($210.7million), compared with 1.866 billion guilders in the same periodlast year.

Sales increased 9% in the company's professional products andsystems division, which includes Philips Medical Systems InternationalBV, while the division posted a loss of 79 million guilders ($46.4million).

Philips said an anticipated recovery of sales and income hasnot materialized. Income was affected by negative developmentsin the semiconductor industry, as well as by costs associatedwith its entry into consumer communications.

In a meeting with analysts, Boonstra said he would aggressivelytackle the company's profitability problems. Philips said it wouldtake a pre-tax charge of 1 billion guilders ($587 million) inits fourth quarter as part of its recovery program, although thecompany declined to state what specific actions it would take.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.